Aleksandar Plamenov Atanasov

Mr. Aleksandar Plamenov Atanasov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Stéphanie Rochetti do AmaralStéphanie Rochetti do Amaral
Stéphanie Rochetti do Amaral
Camila AmantinoCamila Amantino
Camila Amantino
AAAleksandar Plamenov Atanasov
Aleksandar Plamenov Atanasov
Stefanie Oliveira de SousaStefanie Oliveira de Sousa
Stefanie Oliveira de Sousa
RMRichard Moakes
Richard Moakes
Fernando Lucas PrimoFernando Lucas Primo
Fernando Lucas Primo
Skin inflammation associated with chronic diseases involves a direct role of keratinocytes in its immunopathogenesis, triggering a cascade of immune responses. Despite this, highly targeted treatments remain elusive, highlighting the need for more specific therapeutic strategies. In this study, nanocapsules containing quinizarin (QZ/NC) were developed and evaluated in an in vitro model of keratinocyte-mediated inflammation, incorporating the action of photodynamic therapy (PDT) and analyzing permeation in a 3D skin model. Comprehensive physicochemical, stability, cytotoxicity, and permeation analyses of the nanomaterials were conducted. The nanocapsules demonstrated desirable physicochemical properties, remained stable throughout the analysis period, and exhibited no spectroscopic alterations. Cytotoxicity tests revealed no toxicity at the lowest concentrations of QZ/NC. Permeation and cellular uptake studies confirmed QZ/NC permeation in 3D skin models, along with intracellular incorporation and internalization of the drug, thereby enhancing its efficacy in drug delivery. The developed model for inducing the inflammatory process in vitro yielded promising results, particularly when the synthesized nanomaterial was combined with PDT, showing a reduction in cytokine levels. These findings suggest a potential new therapeutic approach for treating inflammatory skin diseases.

21 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Stéphanie Rochetti do AmaralStéphanie Rochetti do Amaral
Stéphanie Rochetti do Amaral
CACamila Fernanda Amantino
Camila Fernanda Amantino
AAAleksandar Plamenov Atanasov
Aleksandar Plamenov Atanasov
SSStefanie Souza
Stefanie Souza
RMRichard Moakes
Richard Moakes
Fernando Lucas PrimoFernando Lucas Primo
Fernando Lucas Primo
Skin inflammation associated with chronic diseases has the direct action of keratinocytes in its immunopathogenesis, leading to a series of immune responses. However, there are still no highly targeted treatments, and the development of more specific therapies is highly desirable. In the present work, nanocapsules containing quinizarin (QZ/NC) were developed, evaluating their act in a model of the keratinocytes inflammatory process in vitro with the action of Photodynamic Therapy, analyzing the permeation in a 3D skin model. Physicochemical, stability, cytotoxicity and permeation analyses of the nanomaterials were carried out. The nanocapsules showed desirable physicochemical characteristics and were stable during the analysis period, without spectroscopic modifications. The cell viability test carried out showed no cytotoxicity at the lowest QZ/NC concentrations. The permeation and cellular uptake studies showed the permeation of QZ/NC in 3D skin models and the intracellular incorporation and internalization of the drug, enhancing its action in the drug delivery technique. Promising results were presented using the model developed to induce the inflammatory process in vitro and applying the synthesized nanomaterial in conjunction with PDT, where a decrease in the levels of cytokines analyzed was observed, representing a possible new therapeutic approach for inflammatory skin diseases.